Abstract
Interleukin-1β (IL-1β) induces the expression of matrix metalloproteinases (MMPs) implicated in cartilage and joint degradation in osteoarthritis (OA) and rheumatoid arthritis (RA). Polyoxypregnane glycoside (PPG), active compound was identified from Dregea volubilis extract by chemical analysis, shown to exert chondroprotective effects in cartilage explant models. However, no studies have been undertaken for the molecular investigation of whether PPG constituents protect the human articular chondrocyte (HAC). In the present studies, HAC was co-treated with IL-1β and PPG. The expression of MMPs, type II collagen, phosphorylation of mitogen-activated protein kinases (MAPKs) and NF-κB signaling pathway were determined by Western immunoblotting. PPG (6.25–25 μM) decreased the IL-1β-induced HA release from chondrocyte to culture medium. The mode of action of PPG was likely mediated through inhibiting expression of MMP-1, -3 and -13 in the medium, which was associated with the inhibition of mRNA expression. PPG had no effect on IL-1β-induced phosphorylation of MAPK pathway. Conversely, PPG decreased phosphorylation of IκB kinase and IκBα degradation. Taken together, these results indicate that PPG may inhibit cartilage degradation in OA and may also be used as nutritional supplement for maintaining joint integrity and function.
Similar content being viewed by others
References
Berenbaum F. Signaling transduction: target in osteoarthritis. Curr. Opin. Rheumatol. 16: 616–622; 2004.
Brandt K. Definition of osteoarthritis. In: Diagnosis and nonsurgical management of osteoarthritis. pp 17–19; 2000.
Brinkerhoff C. E.; Matrisian L. M. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell. Biol. 3: 207–214; 2002.
Burrage P. S.; Mix K. S.; Brinckerhoff C. E. Matrix metalloproteinases: role in arthritis. Front. Biosci. 11: 529–453; 2006.
Dean D. D.; Martel-Pelletier J.; Pelletier J. P.; Howell D. S.; Woessner Jr. J. F. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J. Clin. Invest. 84: 678–685; 1989.
Fenton J. I.; Chlebek-Brown K. A.; Peters T. L.; Caron J. P.; Orth M. W. Glucosamine HCl reduces equine articular cartilage degradation in explant culture. Osteoarthr. Cartil. 8: 258–265; 2000.
Fernandes J. C.; Martel-Pelletier J.; Pelletier J. P. The role of cytokines in osteoarthritis pathophysiology. Biorheology. 39: 237–246; 2002.
Flannery C. R.; Little C. B.; Hughes C. E.; Caterson B. Expression and activity of articular cartilage hyaluronidases. Biochem. Biophys. Res. Commun. 251: 824–829; 1998.
Kim K. S.; Choi H. M.; Bang J. S.; Ryu C. J.; Kim J. H.; Yoo M. C.; Yang H. I. Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes. Eur. J. Pharmacol. 613: 167–175; 2009.
Kirkham B. Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis. Ann. Rheum. Dis. 50: 395–400; 1991.
Knauper V.; Lopez-Otin C.; Smith B.; Knight G.; Murphy G. Biochemical characterization of human collagenase-3. J. Biol. Chem. 271: 1544–1550; 1996.
Kongtawelert P.; Ghosh P. An enzyme-linked immunosorbent-inhibition assay for quantitation of hyaluronan (hyaluronic acid) in biological fluids. Anal. Biochem. 178: 367–372; 1989.
Konttinen Y. T.; Ceponis A.; Takagi M.; Ainola M.; Sorsa T.; Sutinen M.; Salo T.; Ma J.; Santavirta S.; Seiki M. New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above. Matrix Biol. 17: 585–601; 1998.
Koskinen A.; Vuolteenaho K.; Nieminen R.; Moilanen T.; Moilanen E. Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients. Clin. Exp. Rheumatol. 29: 57–64; 2011.
Laurent T. C. Hyaluronan as a clinical marker of pathological processes: in the chemistry, biology and medical applications of hyaluronan and its derivatives. 72: 305–313; 1998.
Little C. B.; Flannery C. R.; Hughes C. E.; Mort J. S.; Roughley P. J.; Dent C.; Caterson B. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem. J. 344: 61–68; 1999.
Liu F. C.; Hung L. F.; Wu W. L.; Chang D. M.; Huang C. Y.; Lai J. H.; Ho L. J. Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products-stimulated chondrocytes. Arthritis Res. Ther. 12: R167; 2010.
Livak K. J.; Schmittgen T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-deltaCt method. Methods 25: 402–408; 2001.
Lotz M. Cytokines in cartilage injury and repair. Clin. Orthop. 391: 108–115; 2001.
Loyau G.; Pujol J. P. The role of cytokines in the development of osteoarthritis. Scand. J. Rheumatol. Suppl. 81: 8–12; 1990.
Mengshol J. A.; Vincenti M. P.; Coon C. I.; Barchowsky A.; Brinkerhoff C. E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase-13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase and nuclear factor kappaB. Differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 43: 801–811; 2000.
Mitchell P. G.; Magna H. A.; Reeves L. M.; Lopresti-Morrow L. L.; Yocum S. A.; Rosner P. J.; Geoghegan K. F.; Hambor J. E. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97: 761–768; 1996.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55–63; 1983.
Panda N.; Mandal N. B.; Banerjee S.; Sahu N. P.; Koike K.; Nikaido T.; Weber M.; Luger P. Polyhydroxy pregnanes from Dregea volubilis. Tetrahedron 59: 8399–8403; 2003.
Piecky M.; Anderson P. Signal transduction in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 15: 789–803; 2001.
Robbins J. R.; Thomas B.; Tan L.; Choy B.; Arbiser J. L. Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1beta. Arthritis Rheum. 43: 2189–2201; 2000.
Roman-Blas J. A.; Jimenez S. A. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthr. Cartil. 14: 839–848; 2006.
Sampson P. M.; Rochester C. L.; Freundlich B.; Elias J. A. Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. J. Clin. Invest. 90: 1492–1503; 1992.
Sangha O. Epidemiology of rheumatic diseases. Rheumatology 39: 3–12; 2000.
Sanyacharernkul S.; Itthiarbha A.; Kongtawelert P.; Meepowpan P.; Nuntasaen N.; Pompimon W. A New Polyoxypregnane Glycoside from the Roots of Dregea volubilis (L.f) Benth. ex Hook. f and its Chondroprotective Effect. Am. J. Biochem. Biotechnol. 5: 202–209; 2009.
Shlopov B. V.; Gumanovskaya M. L.; Hasty K. A. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis. Arthritis Rheum. 43: 195–205; 2000.
Sinkov V.; Cymet T. Osteoarthritis: understanding the pathophysiology, genetics, and treatments. J. Natl Med. Assoc. 95: 475–482; 2003.
Tachakittirungrod S.; Okonogi S.; Chowwanapoonpohn S. Study on antioxidant activity of certain plants in Thailand: Mechanism of antioxidant action of guava leaf extract. Food Chem. 103: 381–388; 2007.
Tetlow L. C.; Adlam D. J.; Woolley D. E. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenera- tive changes. Arthritis Rheum. 44: 585–594; 2001.
Tew S. R.; Hardingham T. E. Regulation of SOX9 mRNA in human articular chondrocytes involving p38 MAPK activation and mRNA stabilization. J. Biol. Chem. 281: 39471–39479; 2006.
Vankemmelbeke M.; Dekeyser P. M.; Hollander A. P.; Buttle D. J.; Demeester J. Characterization of helical cleavages in type II collagen generated by matrixins. Biochem. J. 330: 633–640; 1998.
Vincenti M. P.; Brinkerhoff C. E. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 4: 157–164; 2002.
Visse R.; Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function and biochemistry. Circ. Res. 92: 827–839; 2003.
Wood D. D.; Ihrie E. J.; Dinarello C. A.; Cohen P. L. Isolation of an interleukin-1-like factor from human joint effusions. Arthritis. Rheum. 26: 975–983; 1983.
Acknowledgment
The authors would like to acknowledge financial support from the Thailand Excellence Centre for Tissue Engineering and Stem Cells, Department of Biochemistry, Faculty of Medicine, Chiang Mai University and Chiang Mai Graduate School for the financial support.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: T. Okamoto
Rights and permissions
About this article
Cite this article
Itthiarbha, A., Phitak, T., Sanyacharernkul, S. et al. Polyoxypregnane glycoside from Dregea volubilis extract inhibits IL-1β-induced expression of matrix metalloproteinase via activation of NF-κB in human chondrocytes. In Vitro Cell.Dev.Biol.-Animal 48, 43–53 (2012). https://doi.org/10.1007/s11626-011-9475-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-011-9475-7